NORWALK,Conn.,Jan. 22,2025 -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL),a leading global solar project developer,owner,and operator,today announced the sale of a 17 MW operational solar portfolio in Poland,composed of a previously announced 15 MW under a Power Purchase Agreement (PPA) and an additional 2 MW,all developed and constructed by Emeren and sold together as a package deal. It supports Poland's climate goals and energy transition by integrating renewable energy into the grid. The project contributes to local economic growth by creating construction and long-term jobs while generating annual tax revenues to support infrastructure and community development.
Yumin Liu,CEO of Emeren Group,stated,"The successful development,construction,and sale of this 17 MW solar portfolio highlight our commitment to advancing impactful renewable energy initiatives and delivering meaningful value to our stakeholders. This achievement reinforces Emeren's position as a trusted leader in key markets like Poland,where we actively support both local energy transitions and global sustainability objectives. By collaborating with committed partners,we aim to deliver clean energy solutions that not only address environmental goals but also contribute to long-term community growth and resilience."
About Emeren Group Ltd
Emeren Group Ltd (NYSE: SOL),a renewable energy leader,showcases a comprehensive portfolio of solar projects and Independent Power Producer (IPP) assets,complemented by a significant global Battery Energy Storage System (BESS) capacity. Specializing in the entire solar project lifecycle — from development through construction to financing — we excel by leveraging local talent in each market,ensuring our sustainable energy solutions are at the forefront of efficiency and impact. Our commitment to enhancing solar power and energy storage underlines our dedication to innovation,excellence,and environmental responsibility. For more information,go to www.emeren.com.
For investor and media inquiries,please contact:
Emeren Group Ltd - Investor Relations
+1 (925) 425-7335
The Blueshirt Group
Gary Dvorchak
+1 (323) 240-5796
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors